Clinical Trials Logo
  1. Home
  2. Kidney Transplantation
  3. NCT04363515
  4. Details
NCT04363515 Clinical Trial

Pilot Social Support Counseling Intervention for Kidney Transplant Candidates

Kidney Transplant Clinical Trial

Official title:
Pilot Social Support Counseling Intervention for Kidney Transplant Candidates

Clinical Trial Details — Status: Enrolling by invitation

Administrative data
NCT number NCT04363515
Other study ID # HSR 19-4710
Secondary ID
Status Enrolling by invitation
Phase N/A
First received
Last updated
Start date August 1, 2020
Est. completion date April 30, 2021

Study information
Verified date October 2020
Source Hennepin Healthcare Research Institute
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Pilot social support counseling intervention for kidney transplant candidates

Description:

Individuals who are eligible for kidney transplant will be randomized into two groups, control and interventional counseling. The control group will be given a simple survey to fill and return while the interventional counseling will go through a second counseling session along with members of their social support networks. The interventional counseling will then complete the survey (same as control group). Survey answers will be recorded within REDCAP.

Recruitment information / eligibility
Status Enrolling by invitation
Enrollment 90
Est. completion date April 30, 2021
Est. primary completion date April 30, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - Between ages 18-80 - Being considered for kidney transplant - Part of social support network for an individual being considered for kidney transplant. - Physically and Mentally able to participate.

Study Design

Related Conditions & MeSH terms

Intervention

Behavioral:
• Social support network counseling intervention
Pilot social support counseling intervention for kidney transplant candidates along with their social support networks

Locations
Country Name City State
United States Hennepin Healthcare Research Institute Minneapolis Minnesota

Sponsors (2)
Lead Sponsor Collaborator
Hennepin Healthcare Research Institute University of Minnesota

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Individuals looking to undergo the kidney transplant process and further understanding transplant counseling. Getting listed for kidney transplant 6 months
Secondary Individuals acquiring more knowledge of kidney transplant questionnaire (no scale) 1 month
Secondary Individuals understanding Decisional Conflicts with kidney transplants questionnaire (no scale) one month
See also
  Status Clinical Trial Phase
Completed NCT04087720 - Study of Pegloticase in Participants With Uncontrolled Gout Who Have Had a Kidney Transplant Phase 4
Completed NCT03749356 - Study to Evaluate the Efficacy and Safety of Once-Daily Tacrolimus in Kidney Transplant Recipients Phase 4
Withdrawn NCT05811468 - Study Correlation Between Blood, Tissue Gene Expression, Donor Derived Cell Free DNA and Histopathology in Kidney Transplant Recipients
Completed NCT03527238 - Optimizing Immunosuppression Drug Dosing Via Phenotypic Precision Medicine Phase 2
Completed NCT00498576 - Melatonin and Adiponectin in Hypertensive Kidney Transplant N/A
Completed NCT00642655 - Rituximab and Intravenous Immunoglobulin (IVIG) for Desensitization in Renal Transplantation Phase 1/Phase 2
Completed NCT00374400 - The Paired Donation Consortium Paired Donation Program N/A
Completed NCT01710033 - A Study Of CP-690,550 In Stable Kidney Transplant Patients Phase 1
Completed NCT00205257 - Prediction of Acute Rejection in Renal Transplant Phase 1
Completed NCT02711826 - Treg Therapy in Subclinical Inflammation in Kidney Transplantation Phase 1/Phase 2
Withdrawn NCT03978494 - Study to Compare Pharmacokinetics of Tacrolimus Prolonged-release (PR) Capsules and Advagraf® PR Capsules in Stable Kidney Transplant Patients. Phase 1
Completed NCT03837522 - Trial to Define the Benefits and Harms of Deceased Donor Kidney Procurement Biopsies N/A
Not yet recruiting NCT06025240 - Expanding the Scope of Post-transplant HLA-specific Antibody Detection and Monitoring in Renal Transplant Recipients
Completed NCT05029310 - Effects of Patiromer on Pharmacokinetics of Immunosuppresive Drugs in Renal Transplant Recipients Phase 4
Completed NCT03644485 - Clinical Outcome of Delayed or Standard Prograf Together With Induction Therapy Followed by Conversion to Advagraf in Donation After Cardiac (or Circulatory) Death (DCD) Kidney Transplant Recipients Phase 4
Active, not recruiting NCT02409901 - Effects of Personalized Physical Rehabilitation in Kidney Transplant Recipients N/A
Completed NCT01047410 - ACtive Care After Transplantation, the ACT Study N/A
Completed NCT00940940 - Safety and Immunogenicity of Zostavax Vaccine in Patients Undergoing Living Donor Kidney Transplantation Phase 4
Completed NCT00270712 - A Study of Factors That Affect Long-Term Kidney Transplant Function
Completed NCT00217126 - The Study of Long-term Deterioration of Kidney Transplants. Phase 4